BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25689036)

  • 21. Genetic predictors of interindividual variability in hepatic CYP3A4 expression.
    Lamba V; Panetta JC; Strom S; Schuetz EG
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1088-99. PubMed ID: 19934400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of CYP expression in hepatoma cells stably transfected by chimeric nuclear receptors.
    Küblbeck J; Reinisalo M; Mustonen R; Honkakoski P
    Eur J Pharm Sci; 2010 Jul; 40(4):263-72. PubMed ID: 20381613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene.
    Pavek P; Pospechova K; Svecova L; Syrova Z; Stejskalova L; Blazkova J; Dvorak Z; Blahos J
    Biochem Pharmacol; 2010 Jan; 79(2):277-87. PubMed ID: 19712670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity.
    Lim YP; Cheng CH; Chen WC; Chang SY; Hung DZ; Chen JJ; Wan L; Ma WC; Lin YH; Chen CY; Yokoi T; Nakajima M; Chen CJ
    Arch Toxicol; 2015 Jan; 89(1):57-72. PubMed ID: 25069801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.
    Park YJ; Lee EK; Lee YK; Park DJ; Jang HC; Moore DD
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):131-7. PubMed ID: 22503787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family.
    Riffel AK; Schuenemann E; Vyhlidal CA
    Mol Pharmacol; 2009 Nov; 76(5):1104-14. PubMed ID: 19706729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
    Li T; Chiang JY
    Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR.
    Kanno Y; Tanuma N; Yazawa S; Zhao S; Inaba M; Nakamura S; Nemoto K; Inouye Y
    Drug Metab Dispos; 2016 Aug; 44(8):1158-63. PubMed ID: 27197997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR.
    Luckert C; Ehlers A; Buhrke T; Seidel A; Lampen A; Hessel S
    Toxicol Lett; 2013 Oct; 222(2):180-8. PubMed ID: 23845848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
    Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
    Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90α, and RXRα.
    Zhang L; Yan J; Liu J; Meng C; Liu F; Xia C
    Phytomedicine; 2022 Jul; 101():154097. PubMed ID: 35417848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
    Vyhlidal CA; Bi C; Ye SQ; Leeder JS
    Drug Metab Dispos; 2016 Jul; 44(7):1020-6. PubMed ID: 26772622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive androstane receptor weakens the induction of panaxytriol on CYP3A4 by repressing the activation of pregnane X receptor.
    Hu Q; Yao N; Wu J; Liu M; Liu F; Zhang H; Xiong Y; Xia C
    Biochem Pharmacol; 2019 Jan; 159():32-39. PubMed ID: 30414935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.
    Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    Biochem Biophys Res Commun; 2002 Apr; 293(1):145-9. PubMed ID: 12054576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.
    Oliver P; Lubomirov R; Carcas A
    Clin Chem Lab Med; 2010 May; 48(5):635-9. PubMed ID: 20218903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.
    Takagi S; Nakajima M; Mohri T; Yokoi T
    J Biol Chem; 2008 Apr; 283(15):9674-80. PubMed ID: 18268015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.
    Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo.
    Klein K; Thomas M; Winter S; Nussler AK; Niemi M; Schwab M; Zanger UM
    Clin Pharmacol Ther; 2012 Jun; 91(6):1044-52. PubMed ID: 22510778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scutellarin Mediates Cytochrome P450 3A4 and 2C19 Expression via Pregnane X Receptor and Constitutive Androstane Receptor.
    Huang H; Cao C; Miao Z; Yang X; Lai Y
    Curr Mol Pharmacol; 2023; 16(6):640-653. PubMed ID: 36017831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.